2025-04-08 18:50:14
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Dr Reddy's Laboratories consolidated Q3FY22 PAT at Rs. 706.5 crores
Posted On : 2022-01-28 14:29:04( TIMEZONE : IST )
Dr. Reddy's Laboratories Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 5319.7 crores during the period ended December 31, 2021 as compared to Rs. 5763.2 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 706.5 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 992 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 42.48 for the period ended December 31, 2021 as compared to Rs. 59.65 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 5319.7 crs | ₹5763.2 crs |  -7.70% |
| Net Profit | ₹706.5 crs | ₹992 crs | -28.78% |
| EPS | ₹42.48 | ₹59.65 | -28.78% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 5319.7 crores during the period ended December 31, 2021 as compared to Rs.4929.6 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.706.5 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.19.8 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.42.48 for the period ended December 31, 2021 as compared to Rs.1.19 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 5319.7 crs | ₹4929.6 crs |  7.91% |
| Net Profit | ₹706.5 crs | ₹19.8 crs | 3,468.18% |
| EPS | ₹42.48 | ₹1.19 | 3,469.75% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs. 16002.3 crores during the 9 Months period ended December 31, 2021 as compared to Rs.14243.8 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.2269.3 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.1361.4 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.136.48 for the 9 Months period ended December 31, 2021 as compared to Rs.81.85 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹ 16002.3 crs | ₹14243.8 crs | 12.35% |
| Net Profit | ₹2269.3 crs | ₹1361.4 crs | 66.69% |
| EPS | ₹136.48 | ₹81.85 | 66.74% |
Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 4256.45 as compared to the previous close of Rs. 4407.00. The total number of shares traded during the day was 26994 in over 7182 trades.
The stock hit an intraday high of Rs. 4348.25 and intraday low of 4236.00. The net turnover during the day was Rs. 115657423.00.
